Plasmapp Co

Plasmapp Co EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Plasmapp Co (405000.KQ) as of Nov 3, 2026 is -4.38. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -1.75 — a change of 150.27% (lower).

EV/FCF

-4.38

YoY

150.27%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Plasmapp Co is 2025 -4.38 . EV/FCF (Enterprise Value to Free Cash Flow) of Plasmapp Co was 2024 -1.75 . It decreases by 150.27% lower compared to the previous year.

The Plasmapp Co EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2021
-1.71 KRW
Jan 1, 2022
-1.22 KRW
Jan 1, 2023
-1.15 KRW
Jan 1, 2024
-1.75 KRW
Jan 1, 2025
-4.38 KRW
The Plasmapp Co EV/FCF history
YEAREV/FCFYoY
-4.38+150.27%
-1.75+51.79%
-1.15-5.44%
-1.22-28.97%
-1.71—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Plasmapp Co Stock analysis

What does Plasmapp Co do? Plasmapp Co. Ltd. generates revenue through the provision of low temperature plasma sterilization solutions and implant regeneration and activation solutions. The company manufactures and sells medical devices including sterilizers, sterile consumables, regenerative activators, and related accessories. Its primary customers are healthcare providers and medical institutions requiring advanced sterilization and regenerative treatments. The firm targets the medical device segment with a focus on innovative plasma engineering applications for healthcare applications. The company's product portfolio consists of sterilizers, sterile consumables, regenerative activators, consumables, and accessories. These products are sold directly to healthcare facilities and medical institutions. The firm's technology enables low temperature plasma sterilization, which is critical for sensitive medical equipment and implant procedures. This specialization positions Plasmapp as a provider of niche medical solutions in the healthcare sector. Plasmapp Co. Ltd. focuses on the medical device market segment, particularly for sterilization and regenerative applications. The company's offerings include both hardware solutions like sterilizers and consumable products such as sterile consumables and regenerative activators. These products serve the needs of healthcare providers seeking efficient and advanced medical treatment solutions. Plasmapp Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Plasmapp Co stock

EV/FCF (Enterprise Value to Free Cash Flow) of Plasmapp Co is -4.38 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Plasmapp Co changed from -1.75 to -4.38, representing a 150.27% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Plasmapp Co since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Plasmapp Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Plasmapp Co

All Key Metrics — Plasmapp Co